Stocks to buy

Operating in a niche sector you might have never even considered. AquaBounty Technologies (NASDAQ:AQB) specializes in environmentally responsible fish farming techniques. If you like what you’ve heard so far, then AQB stock might be for you. Source: Pavel Kapysh / Shutterstock.com In the realm of fish farming, land-based aquaculture is a growing trend. AquaBounty’s aquaculture technologies
0 Comments
When Palantir’s (NASDAQ:PLTR) Chief Executive Officer Alex Karp said that short-term investors should look elsewhere, it undermined ARK Invest’s recent PLTR stock purchase. Source: Sundry Photography / Shutterstock.com Investors need to read the context before selling or avoiding PLTR stock. CEO Karp expressed frustration in Wall Street’s short-term thinking, not investment generally. Palantir’s long-term investments
0 Comments
Over the counter (OTC) stocks refer to securities transacted via a dealer network instead of on a centralized exchange such as the Nasdaq or New York Stock Exchange. These exchanges have less severe financial-disclosure requirements and are also known as “pink sheets,” referring to the color of paper on which stock prices were printed before
0 Comments
After Ayro (NASDAQ:AYRO) announced a promising partnership and unveiled a new electric vehicle (EV) that I believe has a great deal of potential, the outlook of AYRO stock continues to be very favorable. Source: Alexandru Nika / Shutterstock.com Further, certain aspects of Ayro’s recent sales of its new shares bode well for its stock price.
0 Comments
Despite an up-and-down performance so far in 2021, Nano Dimension (NASDAQ:NNDM) stock has had an extraordinary 12-month run. Source: shutterstock.com/Alex_Traksel The Israeli 3D printing company is up only 1.65% year-to-date, but that includes wild swings that saw the NNDM stock price soar by 83% and tumble by more than 50%. Over the last 12 months,
0 Comments
New Jersey-based Citius Pharmaceuticals (NASDAQ:CTXR) could simply be pigeonholed as a medical product company. But that’s an oversimplification. Prospective CTXR stock investors deserve a much more in-depth discussion of this fascinating company. Source: Iryna Imago / Shutterstock.com Citius describes itself as a “late-stage specialty pharmaceutical company” that develops and commercializes “critical care products, with a particular
0 Comments